|Articles|March 8, 2016
MM LAB Software Matches Oncology Patients to Treatments
The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs.
Advertisement
MolecularMatch, a personalized cancer treatment company launched its MM LAB software, which is available through an online portal. The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs, in real-time. After test results are matched to treatments in MM LAB, the options are curated by the client laboratory's staff and included in the reports sent back to physicians and patients. The solution works using molecular science / artificial intelligence based algorithms.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
5